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(57) ABSTRACT
A system and method for separating a venous component
and an arterial component from a red signal and an infrared
signal of a PPG sensor is provided. The method uses the
second order statistics of venous and arterial signals to
separate the venous andarterial signals. After reliable sepa-
ration of the venous andthe arterial componentsignals, the
component signals can be used for different purposes. In a
preferred embodiment, the respiratory signal, pattern, and
rate are extracted from the separated venous component and
a reliable “ratio of ratios” is extracted for SpO, using only
the arterial component of the PPG signals. The disclosed
embodiments enable real-time continuous monitoring of
respiration pattern/rate and site-independentarterial oxygen
saturation.
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METHODS AND SYSTEMS FOR
EXTRACTING VENOUS PULSATION AND
RESPIRATORY INFORMATION FROM
PHOTOPLETHYSMOGRAPHS
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application is a continuation in part of U.S. appli-
cation Ser. No. 14/595,866filed Jan. 13. 2015, which claims
priority benefit from U.S. Provisional Application No.
61/926,773, filed Jan. 13, 2014. This application claims
priority benefit from U.S. Provisional Application No.
62/012,720, filed Jun. 16, 2014. Each patent application
identified above is incorporated herein by reference in its
entirety to provide continuity of disclosure.
FIELD OF THE INVENTION
The present invention relates to monitoring a human’s
circulatory system. In particular, the present invention
relates to arterial oxygen saturation monitoring and systems
and methods for extracting information from photoplethys-
mographic sensors. The present invention further relates to
healthcare, systems and methods for human health monitor-
ing, and systems and methods for human circulation system
monitoring.
BACKGROUND OF THE INVENTION
One of the main applications of photoplethysmographic
(PPG) biosensors is measuring blood oxygensaturation. The
commercial device based upon this technology is a pulse
oximeter. Pulse oximetry may be used to quantify various
blood flow characteristics including arterial oxygen satura-
tion, the volumeofblood pulsation carried to the tissues, and
the heart rate. A pulse oximeter typically uses two light
emitting diodes (LEDs) with wavelengths in red and infrared
regions which emit light at a measurementsite on a human
body. A photodetector captures the transmitted or reflected
light. The analog front-end hardware uses a time multi-
plexed approach with three phases: (1) an activated red LED
phase, (ii) an activated infrared LED phase, and(iii) a dark
phase. A transimpedance amplifier amplifies the current
generated in the photodetector due to optical density during
active phases and provides a voltage signal. The voltage
signal is filtered, amplified, and sampled with an analog-to-
digital converter for further processing.
At the measurementsite (e.g. finger, ear, forehead, nasal),
the tissue slightly expands during each heart beat as blood
enters via arteries during systole. Then, the site contracts as
blood leaves during diastole. As a result, the path length of
the light will periodically change. Absorption is proportional
to the optical path length according to the Lambert law of
optical density and the blood volume change will be
reflected in the output of the photodetector. Referring to
FIG.1, the light absorbanceat sensorsite 100 has three main
signal components: a nonpulsatile component 101 origi-
nated from nonpulsatile blood, tissue pigmentation (e.g.
skin, bone, muscle), which results in a direct current (DC)
signal in the photodetector, a weaker signal 102 caused by
blood return in veins, and a dominant alternating current
(AC) 103 caused by blood volume changein arteries.
Light absorption is also a function of the hemoglobin
concentration in blood and a “ratio of ratios” technique
defines R as an intensity-independent parameter. When R is
large, the blood saturation is low and vice versa. An empiri-
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cal linear calibration curve relates the measured R to oxygen
saturation where R is mathematically expressed as:
ACr/DCp
~ ACir/DCir
Eq. 1
where, AC and DC are the ac and de power of the PPG
signals and indices R and IR refer to red and infrared,
respectively. The existence of the venous component which
has the information of blood return to the heart has been
verified with different techniques, including imaging-based
techniques, such as phase contrast magnetic resonance
angiography.
PPGsensors also capture blood volume changein veins.
The sensor’s output AC current is a mixture of arterial and
venous signals. Existence of the venous component causes
the AC powerof the PPG signals to change which leads to
inaccuracy and false alarms in readings such as oxygen
saturation level. In clinical settings, the venous signal has a
significant effect on the shape of PPG signal and the SpO,
readings. For example, a commercial forehead probe called
The Nellcor™ manufactured by Covidien LP of Mansfield,
Mass. needs to be placed above the eyebrow using a
self-adhesive bandage. However, this forehead sensor is
limited to low saturation readings. In hospital settings using
finger, forehead, and ear sensors, a complex waveform can
be created by the prominent venous component. However,
the powerofthe venous componentsignal differs in various
sensorsites, leading to inaccurate readings. This inaccuracy
is confirmed by applying a pressure dressing to the mea-
surementsite, which weakensthe effect of the venous signal
on the PPG signal.
As seen, venous pulsation remains one of the sources of
inaccuracy in various applications of PPG sensors such as
arterial oxygen saturation. Researchers have collected clini-
cal data on effect of venous signal/pulsation on PPG signal
or pulse oximetry readings. Generally, researchers have
observed occurrences of venous signal pulsation on PPG
signals and attempted to understand how such pulsation
affects the oxygen saturation readings. The main experimen-
tal solution suggested has been control of pressure on the
sensor during signal acquisition.
The prior art has attempted to address these problems
associated with venous signal pulsation with limited suc-
cess. For example, the system for pulse oximetry from
Covidien defines and adjusts the sensitivity level of a PPG
sensor. The sensitivity level is adjusted based on the location
of the measurement displayed to the user. The system also
compares the current R value to historical R values. The
historical value may include measurements from the same
patient or an average value from other patients. However, in
the Covidian system, once a prominent venousis detected,
the reading is stopped or ignored. This is a problem because,
in many applications, such as under anesthesia during sur-
gery, the intermittent and temporary changes of the oxygen
saturation need to be constantly monitored which cannot
occur if the readings are stopped.
Other methods of the prior art include extracting infor-
mation from venous pulsation of the PPG signal by adding
a mechanical vibrator to the sensing part. The mechanical
vibrator works as an actuator that creates an external arti-
ficial perturbation close to the PPG sensor. A pressure
transducer is attachedat a first site and applies a drive signal
at a predetermined frequency. The drive signal causes a
series of pulsations of a predetermined magnitude in the
US 10,206,612 B2
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veins. Then, variations in blood volumein veins are captured
by an optical sensor and used to estimate venous oxygen
saturation. However, in order for the system to function, an
artificial pulsation is needed from a mechanical source.
Since this pulsation is artificial, it does not provide any
insight into the actual blood return and natural venous
functionality.
Based on the negative role of venous pulsation on signal
accuracy, there is a need in the art for a system and method
for extracting venous pulsation from PPGsensors. There is
a need in the art for a system and methodthat addresses the
inaccuracy in measurement of parameters, such as SpO., by
extracting a high-quality venous signal. There is a further
need in the art for a system and method that uses the
extracted venous signal on PPG, by extracting other medi-
cally relevant information, such as respiration rate.
SUMMARY
Asystem and methodfor separating a venous component
and an arterial component from a red signal and an infrared
signal of a PPG sensor is provided. The method uses the
second order statistics of venous and arterial signals to
separate the venous andarterial signals. After reliable sepa-
ration of the venous andthe arterial component signals, the
component signals can be used for different purposes. In a
preferred embodiment, the respiratory signal and rate are
extracted from the separated venous componentanda reli-
able “ratio of ratios” is extracted for SpO, using only the
arterial component of the PPG signals. The disclosed
embodiments enable real-time continuous monitoring of
respiration pattern/rate and site-independentarterial oxygen
saturation.
BRIEF DESCRIPTION OF THE DRAWINGS
In the detailed description of the preferred embodiments
described below, reference is made to the accompanying
drawings.
FIG. 1 is a diagram of different components of a captured
PPGsignal.
FIG. 2A is a schematic of an extraction system of a
preferred embodiment.
FIG. 2B is a flowchart of a method of a preferred
embodiment.
FIG. 3 is a schematic of a postprocessing method of a
preferred embodiment.
FIG. 4 is a schematic of an adaptive filter used in the
postprocessing method.
FIG. 5A is a diagram of a venousreturn during a respi-
ratory pump.
FIG. 5B is a diagram of a venous return during a muscle
pump.
FIG. 6 is a graph of a venous signal sampling for
respiratory signal extraction.
FIG. 7A is a graph of a venous signal sampling window.
FIG.7B is a graph of a venous signal sampling window.
FIG. 7C is a graph of a venous signal sampling window.
FIG.8 is a schematic ofrespiratory signal extraction using
a cardiac gated venousreturn signal.
FIG.9 is a set of graphs for a breathing rate and a variance
of error due to respiratory induced venous return changes.
FIG. 10 is a flow chart of a method for correlation-based
respiration rate extra oil.
DETAILED DESCRIPTION
Tt will be appreciated by those skilled in the art that
aspects of the present disclosure may be illustrated and
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4
described in any of a number of patentable classes or
contexts including any new and useful process or machine or
any new and useful improvement. Aspects of the present
disclosure may be implemented entirely in hardware,
entirely in software (including firmware, resident software,
micro-code, etc.) or combining software and hardware
implementation that may all generally be referred to herein
as a “circuit,” “module,” “component,”or “system.” Further,
aspects of the present disclosure may take the form of a
computer program product embodied in one or more com-
puter readable media having computer readable program
code embodied thereon.
Referring to FIG. 2A, system 250 includes PPG sensor
251 connected to computing device 253. PPG sensor 251
includes red LED 254 and infrared LED 255. Computing
device 253 includes processor 256, memory 257 connected
to processor 256, and display 259 connected to processor
256. Extractor 252 is saved in memory 257 and is executed
by processor 256. Extractor 252 includes extraction method
258, as will be further described below. In a preferred
embodiment, extractor 252 receives a red signal from red
LED 254 and an infrared signal from infrared LED 255.
Extractor 252 processes the red signal andthe infrared signal
according to extraction method 258, as will be further
described below.
In one embodiment, computing device 253 is a personal
computer. In another embodiment, computing device 253 is
a tablet computer. In another embodiment, computing device
253 is a smartphone. Any computing device knownintheart
may be employed.
In one embodiment, computing device 253 is a wearable
device, including a wrist-worn device or an electronic patch.
In this embodiment, processor 256 and memory 257 are
embedded. Any wearable computing device knowninthe art
may be employed.
In a preferred embodiment, display 259 is an organic
light-emitting diode (“OLED”) digital display. Any suitable
display type known in the art may be employed.
In a preferred embodiment, extractor 252 is a set of
software modules including a set offilters and multipliers,
executable by any processor. Any type of implementation
knownin the art, including software implementations, hard-
ware implementations, and any combinations thereof may
be employed.
The operation of PPG biosensors is described by the
Beer-Lambert law wherein transmitted light, I, resulting
from an incident source light, Ip, traveling through a sub-
stance with concentration c and path length 1 at the site of
measurement, is modeled as:
29 &
[=]e* Eq. 2
where¢ is called the extinction coefficient of the absorbance
substanceat the site of measurementandis a function of the
wavelength 4. The optical density, A=e(A)cl, is the negative
natural log ofthe transmitted light I, to incidentlight defined
for both scatterer and non-scatterer. The Schuster’s theory of
optical scattering has been applied to pulse oximetry which
provides more insight to the improvement of the pulse
oximeters compared to the Beer-Lambert law which gives
an approximate estimation about scatterer. The optical den-
sity changes (AA) resulting from arterial blood thickness
change, AD,, is:
Ad=VE(E,+F)Hb,AD,
where E,=S,E,+(1-S,)E,, F is the scattering coeflicient, E,
is the extinction coefficient of oxyhemoglobin, E,. is the
extinction coefficient of deoxyhemoglobin and S, is the
Eq. 3
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oxygen saturation rate. When measured in at least two-
wavelengths, this optical density change is used to derive
parameters such as SpO,. However, the venous pulsation
will be present in the measured optical density and affect the
quality andreliability of the measurement. When more than
one substance (e.g. vein with variable blood volume)
absorbs light in a medium, the total optical density is
modeled as:
 Ad=VE,(E,+F)Hb,AD,AVE(EAF)Hb,AD,
where indices a and v denote artery and vein, respectively.
Tissue pigmentation including skin, bone and muscle results
in wavelength-independent fixed absorption which can be
removed or has no effect on the parameter extraction. To
formulate the problem, assume that a two wavelength PPG
sensor producing two mixed signals x,(n) and x,,(n) corre-
sponding to red and infrared LEDs, respectively, and optical
density changes of AA,(n) and AA,,(n), respectively. x,(n)
and x;,,(n) are linear combinations of arterial and venous
component signals where the extinction coefficient is dif-
ferent at each wavelength. The observation signal corre-
sponding to LEDsis written as:
Eq. 4
x(n)=A s(n) Eq. 5
where x(n)=[x,(n)x,,(n)|” is the PPG sensor’s output corre-
sponding to different wavelengths, s(n)=[s,(n)s,(n)|’ is a
vector including the of arterial signal and venous noise
source and A is the 2x2 mixing matrix.
Every major vessel in the human bodyhasa flow pattern
characteristic that is visible in a time domain signal. These
patterns that are representable in modalities such as spectral
waveforms obtained with Doppler ultrasonography have
been used as diagnosis tools in current practices. As a result,
there is a time coherence andstructure in source signals s(n)
coming from the vein and the artery ofthe measurementsite.
This time coherence and structure will be reflected in the
second orderstatistics (e.g. autocorrelation) of the source
signals and thus is considered as second order stationary
signal in the time interval of measurement.
Given the linear [VA mixing model of Eq. 5, an unsuper-
vised data analysis technique is applied, namely, Blind
Source Separation (BSS), to process the two-channel record-
ing of PPG signals. The BSS technique uses observed
signals x and the IVA mixing model in Eq. 5 to extract
underlying sources of the mixed signals. The solution to the
BSS problem is found by approximating the generalized
eigenvectors of a set of target matrices representing signal
statistics. Therefore, the blind source separation ofarterial
and venoussource signals is accomplished by solving a joint
diagonalization problem. Given a set of k target matrices of
size NxN (ie., C;, Co, ..., C,), the joint diagonalization
problem finds a nonsingular matrix V such that the trans-
formed matrices VC,V" becomesas diagonalas possible for
all k values. By suitably defining the target matrices of the
observation x, the time coherence and time structure of
arterial and venous source signals are used to separate the
observed mixture.
Secondorderstatistics ofthe source signals which capture
the time structure and coherence of vein and arterial source
signals are used to define the target matrices. Covariance
matrices C(x) of the delayed mixed signals are employed
for joint diagonalization in BSS. Thus, C,(x) is defined as:
Ca)4Efx(0)x(t40)}
and is used as a target matrix where E is the expectation over
time t and t is a shift in time domain. Using the IAV mixing
Eq. 6
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model in Eq. 5, it is shown that the covariance of mixed
observation signals, x, is related to covariance of source
signals s by:
C.a)=AC(JAF Eq. 7
where off diagonal cross correlation elements of Ct(s) are
zero due to lack of correlation among source signals and
Ct(s) is assumed to be a diagonal matrix. Hence, mixing
matrix A in the BSS problem is found by diagonalizing the
covariance matrices Ct(x). Assuming A is invertible, this is
expressed as:
CUS)=VC(VF Eq. 8
where V diagonalizes all target matrices Ct(x) simultane-
ously. This meansthat the problem of venousnoise effect in
the PPGsignal is converted to a BSS problem. The BSS
problem is effectively solved by approximate joint diago-
nalization (AJD) of time-lagged covariance matrices of
mixed PPG observation signal in two red and infrared
wavelengths. In order to solve AJD problem, a two stage
algorithm called Second Order Blind Identification (SOBI)
is used, as described below.
Referring to FIG. 2B, method 200 for extracting venous
and pulsation and respiratory information is described. In
step 201, a low passfilter is applied on a red channel and an
infrared channel to remove unwanted frequency content of
red PPG signal 202 and infrared PPG signal 203 in a
preprocessing step. In one embodiment, red PPG signal 202
and infrared PPG signal 203 may be corrupted by motion.In
step 204, the SOBI technique separates the arterial and
venous signal components. The SOBItechnique in step 204
uses the diagonalization of several covariance matrices.
In step 205, a whitening step is performed. The sensor
signals x,(n) and x,,(n) are generally mutually correlated and
the covariance matrix is a full but not diagonal matrix.
“Prewhitening” is accomplished by singular value decom-
position of the covariance matrix at time lag t=O. Prewhit-
ening is applied on mixedsignal vector x(n) to prepare input
signals for robust separation. The sensor signals x(n) is
processed by the following transformation:
=Wx(n)
and the covariance matrix of zero mean vector y becomes:
Eq. 9
Efy(ny(a)} =WC)WE= WAAFWL, Eq. 10
where I, is a unity 2x2 matrix as a result of this transfor-
mation. Consequently, for the whitening matrix W, a unitary
matrix L exists such that WA=L and hence:
A=W'L Eq. 11
where W~!is the inverse of W.
Exploiting the time structure of source signals, the unitary
factor L is obtained from covariance matrices at non-zero
time lags, in other words:
CLY)-WC Eq. 12
where C,(y) is the covariance matrix of y, whitened red and
infrared observation signals. Using Equations (7) and (11),
we have C,(y)=LCt(s)L”. This meansthat L can be obtained
as a unitary diagonalizing matrix C,(y) for non-zero lag Tt.
SOBI technique uses this fact with a set of lagged
covariance matrices C=[Ct,(y), . . . , C,,(y)] where C,,(y)
i=1,...k is a covariance matrix ofy at lag t,. This technique
defines a cost function:
OC, F)=3,.1" OFT*#C,,V) Eq. 13
for joint diagonalization of the lagged covariance matrices.
Off(V"C,,;V) is the summation of square of absolute value of
US 10,206,612 B2
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off diagonal elements in C,,. Minimization of cost function
Q leads to approximate joint diagonalization of covariance
matrices where it uses information of a set of covariance
matrices and it is not required that all C,,’s be exactly
simultaneously diagonalized. There are different numeri-
cally efficient techniques for computation of AJD.
In step 206, a Jacobi technique is generalized for mini-
mization of Q and finding the unitary matrix L. The gener-
alized Jacobi approach computes L using the product of
given rotations. Step 205 provides matrix W and step 206
finds the unitary matrix L for computation of mixing matrix
Ain Eq. 11. Arterial and venous components are separated
by the SOBI technique in step 204. However, a permutation
indeterminacy resolution is needed to label the arterial and
venous components because it is not known which of the
outputs is related to the artery and which oneto the vein.
In step 207,the arterial and venous signal components are
monitored. In step 208, a permutation ambiguity technique
is added to the separated arterial and venous components to
label the arterial and venous components.
The BSSprocess factors the mixed observed signal x into
a mixing matrix A and a vector s. A scalar factor is
exchanged between s,(n) and s,(n) in s and the correspond-
ing columnsofA. This is called “scaling ambiguity” which
means that the amplitude of the source signals is not
uniquely defined. In other words, the mixing matrix is
rewritten as:
N N Eq. 14
x= As= As = » (@jAj\(L/o7js)
j=l 1i
where A, is the j” column ofmatrix A. Moreover, this means
that the sign of the sources cannot be derived. Similarly,
there is also a permutation ambiguity meaning that the order
of the sources is not unique. This is because equation:
x=AP"! Ps Eq. 15
is indistinguishable from Eq. 5, where here P is a permuta-
tion matrix.
This results in separation of the arterial and venous
signals with the linear system of the form:
{ $1(2) = hyp x,(2) + hyrxj-(2) Eq. 16
2(m) = has x,/(1) + ho2xir(n)
where h is a demixing matrix derived from AJD of second
order statistics. Due to permutation ambiguity, it is not
known which source (s, or s,) is the arterial source.
In order to automatically find arterial and venous com-
ponents after separation, time domain characteristics of
arterial and venous components are used. Venous and arte-
rial signals have different time domain behaviors, and so the
statistical properties of these two signals are different. Kur-
tosis of s,; and s, are shown labeled as K,, and K,,. The
arterial signal is more correlated to a sinusoidal signal. So,
the absolute value of difference of each source and 1.5
(kurtosis of sinusoidal) is computed, 1.e. 8,0,rce=!Kyounce
1.5|. Therefore, the 2x2 permutation matrix P is defined to
be a unity matrix when 5s,<és,, and
Eq. 17
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8
otherwise. In other embodiments, similar time domain fea-
tures such as skewness or power analysis of signal in
frequency domain may be used for labeling the arterial and
venous signals.
Returning to FIG. 2B, in step 210 a respiratory signalis
extracted using separated venousandarterial signals, which
will be described further. In step 211, after extracting the
respiratory signal, a correlation-based respiration rate
extractor is used to extract the respiration (e.g., breathing)
rate.
Referring to FIG.3, post processing step 209 is performed
using set offilters 300. Venous reference component 302 is
now usedas a reference noise source in adaptivefilters 304
and 305 to separate arterial and venousportionsofthe signal
from input red and infrared signals 301 and 303, respec-
tively. Adaptive filter 304 receives red signal 301 and venous
reference component 302 and outputs venousred signal 309
and arterial red signal 310. Adaptive filter 305 receives
infrared signal 303 and venous reference component 302
and outputs venousinfrared signal 311 andarterial infrared
signal 312.
Referring to FIG. 4, each of adaptive filters 304 and 305
are further described. Each filter 403 receives venous ref-
erence source 401 and PPG mixed signal 402 and provides
two output signals, venous signal 406 andarterial signal
405. Algorithm 404 controls filter 403 to separate venous
signal 406 andarterial signal 405.
Returning to FIG.3, arterial red and infrared signals 310
and 312 will be used for monitoring SpO,. Each of venous
signals 309 and 311isfiltered with notch filter 307 and 308,
respectively, to suppress the signal power in fundamental
frequency 313 of the PPG signal.
Each of notch filters 307 and 308 of a preferred embodi-
mentis an adaptive combfilter, timing the location of zeros
and poles with fundamental frequency (e.g., Heart Rate) 313
of the signal. Fundamental frequency 313 is extracted at 306
using an autocorrelation based technique andarterial infra-
red signal 312. Fundamental frequency 313 is used in
transfer function:
(l+ag!+z¢7%) Eg. 18
H@= (1 + paz! + p?z-?)
which has two zerosat e®*”, on the unit circle and two poles
on with the same angle andradii of p in the range of about
0.95 to 0.995.
Referring to FIGS. 5A and 5B, the venous return/signal
(e.g., back flow of blood to the heart) is mainly due to
skeletal muscle pumpandrespiratory pump. When muscles
contract, one way valves open and when muscles relax
valves close to prevent back flow of blood. Open valve 501
during muscle contraction 502 is shown in FIG. 55. Another
main contributing factor in pulsating venous return is the
respiratory pump which causes compression and decom-
pression of veins. During inhalation, diaphragm 503 moves
downward which causes a low pressure state in thoracic
cavity 504 and high pressure abdominal cavity. Hence, the
abdominalveins are compressed and blood movesto decom-
pressed thoracic and to the right atrium ofthe heart at 505.
Pressure reverses during exhalation and valves prevent back
flow of the blood. Therefore, blood flow in veins is affected
by respiration and one ofthe applications of the separation
of arterial and venous signals is extraction of respiratory
related information.
US 10,206,612 B2
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In order to extract the respiratory signal, beat-to-beat
variation of the venous return signal using a cardiac gating
approach is employed. Referring to FIG. 6, the biphasic
activity of cardiac cycle includes systole portion 601 and
diastole portion 602. Systole portion 601 has systolic peaks
603. Diastole portion 602 has diastolic peaks 604. The
venous signal is sampled during diastole portion 602 for
extracting the respiratory signal.
Referring to FIGS. 7a, 76, and 7c, different activities
during a cardiac cycle are shown. Whenthe ventricular is not
contracted during diastole 701, the arterial blood flow and
hydrodynamic pressures are minimum. Decreased blood
pressure during diastole 701 results in a weak and low
amplitude arterial signal. During this time duration, the
venous return is still in progress by both respiratory and
skeletal muscle pumps. The arterial signal may be consid-
ered as an interference added to the venoussignal, and the
diastole time duration is the interference or noise-free por-
tions 702, 703, and 704 of the biphasic cardiac cycle.
Therefore, the noise-free portions 702, 703, and 704 of the
extracted venous signal in each cardiac cycle may be
sampled to extract the respiratory signal.
FIG. 76 shows sampling windows702 and 703 ofinterest
during consecutive cardiac cycles. An algorithm is used to
determine the active sampling window in each cardiac cycle,
which will be further described.
FIG. 7c showsactive time duration of sampling during a
signal cardiac cycle. During sampling window 704 venous
pressure 705 changesrapidly to its maximum valueat point
706 while arterial signal 707 has a low amplitude at point
708. Respiration changes the morphological features of this
upward back flow of the blood return including maximum
signal value at point 706.
Referring to FIG. 8, step 210 (of FIG. 2B) is further
described as method 800 for cardiac gating of extracted
venous signal and extracting respiratory signal. In method
800,first derivatives 803 and 804 of original red signal 801
and extracted red venous signal 802, respectively, are taken.
Time domain window signal 805 whose value is 1 during
diastole and zero elsewhere is created. Time domain window
signal 805 is created using time domain window generation
806 as follows: If first order derivative 803 of original red
signal 801 is greater than zero, then time domain window
signal 805 takes zero value. Otherwise, time domain win-
dow signal 805 remains one. This operation makes the
starting point of the PPG signal up to peak systolic points of
the window zero in each cardiac cycle. Next, if first order
derivative 804 of extracted red venoussignal 802 is less than
zero, the corresponding time domain window signal 805
becomes zero. This operation will remove the time duration
between systolic peak and diastolic peak pressures. After
creating time domain window signal 805, which implements
the cardiac gating approach, time domain window signal
805 is multiplied with first order derivative 804 of extracted
red venous signal 802 with multiplier 807 into windowed
first order derivative venous signal 808. Then, in each beat
cycle and during diastole, peak finder 809 finds the maxi-
mum amplitude of windowedfirst order derivative venous
signal 808. The peak value of windowedfirst order deriva-
tive venous signal 808 will change as the respiratory pump
changes the venousreturn in every beat cycle. Sampling rate
of the extracted respiratory induced venousreturn variations
is lower compared to original signal. In fact, there is one
sample per cardiac cycle, hence spline interpolator 810 is
used to interpolate the extracted variation by implementing
a polynomialinterpolation, preferably a spline interpolation,
and filtered with band pass filter 811 to limit the frequency
40
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content of the output signal to preferably the typical fre-
quency of humanrespiration rate (e.g. 4 breaths per minute
to 40 breaths per minute for adults), to build respiratory
signal 812.
Test 1
An experimental platform is developed using finger and
forehead probes with red and infrared LEDs. Analog con-
ditioning circuit limits the bandwidth of the signal to 70 Hz
and data is acquired with sampling rate of 150 Hz using a
TMS320C5515 processor by Texas Instruments. Method
200 removes the venous component from red and infrared
signals and providesarterial red andarterial infrared signals.
So, the ratio of red to infrared signal is computed using
arterial signals by Eq. 1. After extraction of ratio R an
empirical calibration curve is used to compute the arterial
oxygen saturation level SpO,.
A prominent venous component can cause inaccurate
SpO, readings and the power of the venous component
varies in different locations of the body. So, venouseffect is
location sensitive. For example, forehead sensors are shown
to be more sensitive to venous return signal. Further, for the
same measurementsite, the power of the venous component
may change overtime depending on volumeofblood return
due to motion, respiration, etc. The proven causes ofvenous
return change are skeletal muscle pumping andrespiratory
pumping as previously discussed. Therefore, in order to
change venous return and see the effect of venous return
signal changes on the “ratio of ratios” (i.e. SpO,), we can
either change the respiratory pump componentor skeletal
muscle pump. Skeletal muscle pumping can be changed by
motion or exercise. Rate of flow through exercising skeletal
muscles can be 15 to 20 times greater than resting muscles.
Despite the dramatic change of venous return signal during
exercise, the motion artifact significantly reduces the signal
quality and changes will be buried in noise. Therefore, the
effect of such changes on “ratio of ratios” or related SpO,
cannot be easily studied. Hence, an experiment was
designed to validate method 200 in terms of removal of
venous related inaccuracies in “ratio of ratios” measure-
ment. In this experiment, data was collected from twelve
subjects from both a finger sensor and a forehead sensor,
simultaneously. Twenty minutes of data was collected from
each subject. In order to change venousreturn, subjects were
required to changerespiration rate over time in a wide range.
Referring to FIG.9,the pattern of respiratory rate changes
over the course of the experiment for one of the subjects is
shown in graph 901 and the corresponding variance of
difference between readings from forehead and finger sen-
sors is shown in graph 902. In graph 902 variance of error
between forehead and finger “ratio of ratios” is computed
every 26 seconds. The variance of the error is much less for
method 200 plotted as curve 903 than for original PPG
signal curve 904, which means that despite changes in
venous signal due to respiration, method 200 gives similar
readings at the output.
Table 1 below summarizes the variance of difference
between readings using method 200 and standard “ratio of
ratios” on original PPG signal for all subjects. Since method
200 separates the arterial component and the ratio is com-
puted based on arterial component, method 200 significantly
reduces the error between forehead and finger sensors.
US 10,206,612 B2
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VARIANCE OF RATIO DIFFERENCE BETWEEN FOREHEAD AND FINGER SENSOR
Subjects
Methods M-32 M-44 M-50 F-29 M-29 M-21 M-31 F-50 M-59 F-41 F-29 M-25 Average
Prior Art 0.003 0.020 0.040 0.017 0.032 0.086 0.008 0.019 0.0235 0.035 0.078 0.053 0.04
Method
Method 200 2.0e-5-1.07e-4__ 1.3e-4 7.23e-5 4.5e-4 3.53e-4 7.12e-5 5.4e-5 4.34e-5 1.8le-5 3.42e-5 0.5le-4 1.3e-4
Method 200 extracts the venous signal and is employed to
provide other features related to venoussignal, including the
extraction of a respiratory signal in step 210. In step 211, the
monitoring. The experimental results shows that on average
the respiration rate can be computed with 1.89 RMSD
compared to commercially available technologies.
 
respiration rate (numberof breaths per minute) is extracted 15 Tt will be appreciated by those skilled in the art that the
from the respiratory signal. described embodiments disclose significantly more than an
Referring to FIG. 10, step 211 (of FIG. 2B) is further abstract idea including technical advancements in thefields
described as method 1000 for respiration rate extraction. At of healthcare, human health monitoring, and human circu-
step 1002, an autocorrelation function is computed using lation system monitoring, and a transformation of data
respiratory signal 1001 in the lag range corresponding to a 20 which is directly related to real world objects and situations.
human respiration rate range, e.g., 4 breaths per minute to 40 Specifically, the disclosed embodiments generate respira-
breaths per minute for adults. At step 1003, the first domi- tory, blood oxygen, and respiratory signals by detecting
nant peak of the autocorrelation function is found by detec- artery, vein, and tissue movements and transforming such
tion of all local peaks and selecting the peak with highest movements into a set of photoplethysmographic signals. The
amplitude. At step 1004, the fundamental period correspond- > set of photoplethysmographic signals are then transformed
ing to the first peak is divided by interpolation factor 1007 into identifiable and usable arterial and venous signal. The
and provides the numberofheart beats (cardiac cycles) in a arterial and venoussignal are then transformedinto a blood
single respiratory cycle (inspiration and expiration). In this oxygen level and a respiratory rate to determine the health
step, heart rate per minute 1006 is divided by the numberof of a human patient.
beats per respiratory cycle provides respiratory rate per 3° ‘It will be appreciated by those skilled in the art that
minute 1005. modifications can be tirade to the embodiments disclosed
Test 2 and remain within the inventive concept. Therefore, this
In this experiment, data is collected from 12 subjects. invention is not limited to the specific embodiments dis-
Each subject wore a finger sensor and the PPG signals from closed, but is intended to cover changes within the scope and
each sensor are captured for twenty minutes. Simultane- 35 spirit of the claims.
ously, the respiration rate of each subject is monitored and
recorded using a commercial reference sensor. The invention claimedis:
Accuracy of method 1000 is summarized in Table 2 1. A methodfor extracting arterial, venous, blood oxygen,
below. The average Root Mean Square Deviation (RMSD), and respiratory information from a set of photoplethysmo-
i.e., the measure ofdifference between calculated and ref- *° graphic signals comprising the steps of:
erence respiration rates, is 1.89 breaths per minute and preprocessing the set of photoplethysmographic signals;
average standard deviation is 1.54. Average Mean of Dif- locating a venous signal and anarterial signal in each
ference (Diff. Mean) and Mean of Absolute Value of Dif- photoplethysmographic signal of the set of photopl-
ference (Abs. Diff. Mean) for 12 subjects are -0.69 and 1.26 ethysmographic signals, using second order blind iden-
breaths per minutes, respectively. The experimental results 45 tification;
show that the separated venous componenthasthe respira- extracting the arterial signal and the venous signal from
tory pumpandrespiratory induced venousreturn variation. each photoplethysmographic signal of the set of pho-
Further, the respiratory signal was extracted from the sepa- toplethysmographic signals;
rated venous signal and finally, the respiration rate was extracting a respiratory signal using the venoussignal and
computed from the respiratory waveform. the arterial signal; and,
TABLE2
BREATHING RATE ACCURACY
Subject
Parameter M-32 M-44 M-SO F-29 M-29 M-21 M-31 F-5O M-5S9 F-41 F-29 M-25 Average
RMSD 0.87 2.03 187 2.05 154 2.06 245 117 2.66 217 235 156 1.89Diff. Mean -0.28 -0.56 -0.35 -1.27 -0.83 0.12 -1.26 0.61 -1.89 -1.27 -0.97 -0.30 -.69Abs. Diff.Mean 0.65. «1.32 0.79 1.65 1.08 143 1.57 0.92 195 138 1.24 1.23 1.26St. Dev 0.82 195 112 1.6 1.29 205 210 100 187 1.76 136 153 1.54
The experimental results show that compared to standard
techniques, the variance of difference between forehead and 65
finger sensor is negligible. This enables a measurementsite
with independent and accurate arterial oxygen saturation
extracting a blood oxygen saturation from the arterial
signal;
wherein the set of photoplethysmographic signals com-
prises a red signal and an infrared signal;
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wherein the red signal comprises a red venous signal
and a red arterial signal; and,
wherein the step of extracting a respiratory signal
further comprises the steps of:
determining a red signal derivative of the red signal;
determining a red venoussignal derivative for the red
venous signal;
generating a time domain window signal from the red
signal derivative and the red venous signal deriva-
tive;
generating a windowed signal from the time domain
window signal and the red venoussignal derivative;
determining a maximum amplitude from the windowed
signal;
determining a venous return variation from the maxi-
mum amplitude;
interpolating the venous return variation; and,
filtering the venous return variation to generate the
respiratory signal.
2. The method of claim 1, further comprising the stepsof:
computing an autocorrelation function of the respiratory
signal;
determining a peak of the autocorrelation function; and,
calculating a respiratory rate using the peak.
3. The method of claim 1, wherein the step of extracting
the arterial signal further comprises the steps of:
determining a venous reference signal from the set of
photoplethysmographic signals;
filtering the arterial signal from each photoplethysmo-
graphic signal of the set of photoplethysmographic
signals, using the venous reference signal; and,
filtering the venous signal from each photoplethysmo-
graphic signal of the set of photoplethysmographic
signals, using the venous reference signal.
4. The method of claim 3, further comprising the steps of:
extracting a fundamental frequency from the arterial
signal; and,
filtering the venous signal using the fundamental fre-
quency.
5. The method of claim 1, wherein the step of prepro-
cessing further comprises the step offiltering the set of
photoplethysmographic signals with a low pass filter.
6. The method of claim 1, wherein the step of locating
further comprises the steps of:
whitening the set of photoplethysmographic signals; and,
computing an approximate joint diagonalization ofthe set
of photoplethysmographic signals.
7. Amethodfor extracting a respiratory signal and a blood
oxygen level from a red photoplethysmographic signal and
an infrared photoplethysmographic signal comprising the
steps of:
receiving the red photoplethysmographic signal and the
infrared photoplethysmographic signal;
filtering the red photoplethysmographic signal and the
infrared photoplethysmographic signal;
separating the red photoplethysmographic signal into a
first signal component and a second signal component;
separating the infrared photoplethysmographic signal into
a third signal component and a fourth signal compo-
nent;
determining a red venous signal from the first signal
component and a red arterial signal from the second
signal component;
determining an infrared venous signal from the third
signal component and an infrared arterial signal com-
ponent from the fourth signal component;
10
15
20
25
30
35
40
45
50
55
60
14
extracting the red arterial signal and the red venoussignal
from the red photoplethysmographic signal;
extracting the infrared arterial signal and the infrared
venoussignal from the infrared photoplethysmographic
signal;
extracting the respiratory signal using the red photopl-
ethysmographic signal and the red venoussignal; and,
extracting the blood oxygen signal using the red arterial
signal and the infrared arterial signal;
wherein the step of extracting the respiratory signal
further comprises the steps of:
determining a red signal derivative of the red photopl-
ethysmographic signal;
determining a red venous signal derivative of the red
venous signal;
generating a time domain window signal from the red
signal derivative and the red venous signal derivative;
generating a windowed signal from the time domain
signal and the red venous signal derivative;
determining a maximum amplitude from the windowed
signal;
determining a venousreturn variation from the maximum
amplitude;
interpolating the venous return variation; and,
filtering the venous return variation to generate the respi-
ratory signal.
8. The method of claim 7, further comprising the steps of:
computing an autocorrelation function of the respiratory
signal;
determining a peak of the autocorrelation function; and,
calculating a respiratory rate using the peak.
9. The method of claim 7, wherein the step of extracting
the red arterial signal and the red venous signal further
comprises the steps of:
determining a venousreference signal from the red pho-
toplethysmographic signal and the infrared photopl-
ethysmographic signal;
filtering the red arterial signal from the red photoplethys-
mographic signal using the venous reference signal;
and,
filtering the red venous signal from the red photoplethys-
mographic signal using the venous reference signal.
10. The method of claim 9, wherein the step of extracting
the infrared arterial signal and the infrared venous signal
further comprises the steps of:
determining the venous reference signal from the red
photoplethysmographic signal and the infrared photop-
lethysmographic signal;
filtering the infrared arterial signal from the infrared
photoplethysmographic signal using the venousrefer-
ence signal; and,
filtering the infrared venous signal from the infrared
photoplethysmographic signal using the venousrefer-
ence signal.
11. The method of claim 10, further comprising the steps
of:
extracting a fundamental frequency from the infrared
arterial signal;
filtering the red venous signal using the fundamental
frequency; and
filtering the infrared venoussignal using the fundamental
frequency.
12. A system for extracting arterial, venous, blood oxy-
gen, and respiratory information from a set of photoplethys-
mographic signals comprising:
US 10,206,612 B2
15
an extractor;
a set ofphotoplethysmographic sensors outputting a set of
photoplethysmographic signals, each photoplethysmo-
graphic sensor connected to the extractor;
a computing device connected to the extractor and pro-
grammedto:
preprocess the set of photoplethysmographic signals;
locate a venous signal and anarterial signal in each
photoplethysmographic signal of the set of photop-
lethysmographic signals using second order blind
identification;
extract the arterial signal and the venous signal from
each photoplethysmographic signal of the set of
photoplethysmographic signals;
extract a respiratory signal using the venoussignal and
the arterial signal; and,
extract a blood oxygen saturation from the arterial
signal;
wherein each photoplethysmographic sensor comprises
a red LED andan infrared LED;
wherein the set ofphotoplethysmographic signals com-
prises a red signal and an infrared signal;
wherein the red signal further comprises a red venous
signal and a red arterial signal; and,
wherein the computing device is further programmed
to:
receive the red signal from the red LED;
receive the infrared signal from the infrared LED;
determine a red signal derivative of the red signal;
determine a red venous signal derivative for the red
venous signal;
generate a time domain window signal from the red
signal derivative and the red venous signal deriva-
tive;
generate a windowed signal from the time domain
signal and the red venous signal derivative;
determine a maximum amplitude from the windowed
signal;
15
20
25
30
35
16
determine a venousreturn variation from the maximum
amplitude;
interpolate the venous return variation; and,
filter the venous return variation to generate the respi-
ratory signal.
13. The system ofclaim 12, wherein the computing device
is further programmedto:
compute an autocorrelation function of the respiratory
signal;
determine a peak of the autocorrelation function; and,
calculate a respiratory rate using the peak.
14. The system ofclaim 12, wherein the computing device
is further programmedto:
determine a venous reference signal from the set of
photoplethysmographic signals;
filter the arterial signal from each photoplethysmographic
signal of the set of photoplethysmographic signals
using the venous reference signal; and,
filter the venous signal from each photoplethysmographic
signal of the set of photoplethysmographic signals
using the venousreference signal.
15. The system ofclaim 14, wherein the computing device
is further programmedto:
extract a fundamental frequency from thearterial signal;
and,
filter the venous signal using the fundamental frequency.
16. The system of claim 12, wherein the extractor further
comprisesa set offilters, and wherein the computing device
is further programmedto filter the set of photoplethysmo-
graphic signals with the set offilters.
17. The system ofclaim 12, wherein the computing device
is further programmedto:
whiten the set of photoplethysmographic signals; and,
compute an approximate joint diagonalizationoftheset of
photoplethysmographic signals.
* * * * *
